ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Reference29 articles.
1. Renal cancer
2. Overview of current and future systemic therapy for metastatic renal cell carcinoma
3. Quelle place pour la radiothérapie et la chimiothérapie dans le traitement adjuvant des carcinomes urothéliaux des voies excrétrices urinaires supérieures ?
4. The role of endothelial colony forming cells in kidney cancer’s pathogenesis, and in resistance to anti-VEGFR agents and mTOR inhibitors: A speculative review
5. The Current and Evolving Landscape of First-Line Treatments for Advanced Renal Cell Carcinoma
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A multifunctional antibody fusion protein 57103 targeting CD24, IL-4R, and αvβ3 for treating cancer and regulating the tumor microenvironment;Biomedicine & Pharmacotherapy;2024-06
2. Better prediction of clinical outcome in clear cell renal cell carcinoma based on a 6 metabolism-related gene signature;Scientific Reports;2023-07-17
3. Identification of calcium metabolism related score associated with the poor outcome in papillary thyroid carcinoma;Frontiers in Oncology;2023-03-28
4. A novel five-gene metabolism-related risk signature for predicting prognosis and immune infiltration in endometrial cancer: A TCGA data mining;Computers in Biology and Medicine;2023-03
5. A metabolism-related gene signature for predicting the prognosis in thyroid carcinoma;Frontiers in Genetics;2023-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3